Location History:
- Praha, CZ (2012)
- Prague, CZ (2014 - 2015)
Company Filing History:
Years Active: 2012-2015
Title: Innovations of Tomas Pekarek in Pharmaceutical Development
Introduction
Tomas Pekarek is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceuticals, holding three patents that showcase his innovative spirit and dedication to advancing medical science.
Latest Patents
One of his latest patents is titled "Pharmaceutically acceptable cocrystals of N-[2-(7-methoxyl-1-naphtyl)ethyl]acetamide and methods of their preparation." This invention relates to novel solid forms of agomelatine, specifically novel pharmaceutically acceptable cocrystals, along with methods for their preparation. The patent describes three cocrystals that possess physico-chemical properties suitable for pharmaceutical development.
Another significant patent is "Salts of desvenlafaxine and a method of their preparation." This invention focuses on new salts of the desvenlafaxine base with oxalic acid. The new salts include the hydrogen oxalate and hemioxalate forms, which are crucial for enhancing the efficacy of desvenlafaxine in therapeutic applications.
Career Highlights
Tomas Pekarek is currently associated with Zentiva K.s., a company known for its commitment to pharmaceutical innovation. His work at Zentiva has allowed him to explore and develop new pharmaceutical formulations that can improve patient outcomes.
Collaborations
Tomas has collaborated with notable colleagues such as Ludek Ridvan and Gary James Miller. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical research.
Conclusion
Tomas Pekarek's contributions to pharmaceutical innovation through his patents reflect his commitment to improving healthcare solutions. His work continues to influence the field and pave the way for future advancements in medicine.